CROs an Innovation Partner in Clinical Trials
Contact: John Lewis
New ACRO Report Details Cost Saving and Time Saving Clinical Trial Innovations Championed by CROs
Washington, D.C.—As a cap to Clinical Research Innovation Month, the Association of Clinical Research Organizations (ACRO) today released a report titled Clinical Research: A Legacy of Innovation, A Future of Transformed Medicine which showcases advancements in clinical trial processes that have come about as a result of clinical research organization (CRO) innovation. An explanation of the expanding size and scope of CROs globally along with policy recommendations to improve clinical trials in the United States and European Union (EU) and 12 case studies detailing CRO-driven innovation are also featured in the report.
ACRO Executive Director Douglas Peddicord, Ph.D., commented on the report: “ACRO members compete on the basis of innovation. While long recognized for their expertise in managing clinical trials, ACRO members today are using their knowledge and expertise to add value throughout the entire discovery, development, and delivery cycle–from early clinical studies through commercialization and monitoring of new medical products. Sponsors are benefiting from these innovations as are patients, who benefit from having access to new, more individualized treatments much sooner.”
The report’s dozen member company case studies highlight clinical research innovation in areas such as risk-based monitoring, adaptive trial design, enhanced patient recruitment, data analytics, predictive technologies, logistics management, commercialization, and safety monitoring. Time and money saved because of these innovations benefit research sponsors and patients alike.
An excerpt: “Clinical trials today are more responsive, individualized, and effective because it’s written into the DNA of CROs to challenge the status quo. CROs are harnessing real-time data analytics and visual reporting software tools; they’re building innovative strategic partnerships, and breaking down communication barriers between trial sponsors, trial sites, patients, and even regulators.
“These process innovations help patients get access to life-saving treatments faster and encourage continued investment in the development of medicines and rare-disease treatments around the world.”
The Association of Clinical Research Organizations (ACRO) represents companies that provide a variety of specialized services that support the development of new pharmaceuticals, biologics, and medical devices. The Association provides an active voice for the CRO industry globally. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ approximately 100,000 professionals worldwide and conduct research in 142 countries. For more information, please visit www.acrohealth.org. Twitter @acrohealth. YouTube @ACROHealthChannel. Facebook. RebelMouse.